Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer (DTC)
INTERVENTIONAL
Inicio: 15 de nov de 2021
ID: NCT04940052
Completado
Fase 3
ClinicalTrials.gov
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 17 de jun de 2019
ID: NCT03914326
Completado
Fase 3
ClinicalTrials.gov
A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00645099
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Open-Label, Comparator-Controlled Trial to Evaluate the Efficacy and Safety of LY3938577 in Study Participants, With Type 2 Diabetes Previously Treated With Basal Insulin
INTERVENTIONAL
Inicio: 13 de oct de 2025
ID: NCT07215312
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
INTERVENTIONAL
Inicio: 20 de nov de 2023
ID: NCT06077864
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de oct de 2001
ID: NCT00029848
Completado
Fase 2
ClinicalTrials.gov
Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de nov de 2004
ID: NCT00099515
Terminado
ClinicalTrials.gov
Natural History Study of Children With Metachromatic Leukodystrophy
OBSERVATIONAL
Inicio: 2 de nov de 2015
ID: NCT01963650
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose (Rimonabant 20 mg) Multicenter Study of Long-Term Glycemic Control With Rimonabant in Treatment-naïve Patients With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00257257
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease
INTERVENTIONAL
Inicio: 30 de may de 2023
ID: NCT05882045
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess the Efficacy, Safety and Tolerability of Aleglitazar Plus Metformin Combination Therapy Compared With Placebo Plus Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01691846
Completado
Fase 4
ClinicalTrials.gov
A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 30 de mar de 2012
ID: NCT01528254
Completado
ClinicalTrials.gov
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone, PTH (Forteo)
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00365924
Activo, no recluta
Fase 2
ClinicalTrials.gov
A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2a Study Assessing Safety and Efficacy of Brivekimig, a Dual Anti-TNF-α and Anti-OX40L NANOBODY® Molecule, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Recently Diagnosed Type 1 Diabetes
INTERVENTIONAL
Inicio: 28 de feb de 2025
ID: NCT06812988
Completado
Fase 3
ClinicalTrials.gov
A Randomized Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Who Were Previously Treated by Basal Insulin Glargine With Either Metformin or Metformin and Sulfonylurea
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00960661
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
INTERVENTIONAL
Inicio: 18 de nov de 2019
ID: NCT04109066
Reclutando
ClinicalTrials.gov
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
OBSERVATIONAL
Inicio: 1 de jul de 2024
ID: NCT06573723
Completado
Fase 3
ClinicalTrials.gov
A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)
INTERVENTIONAL
Inicio: 10 de ene de 2004
ID: NCT00172172
Completado
ClinicalTrials.gov
A Non-interventional Cross-sectional Study to Capture the Prevalence of Cardiovascular Disease in Patients With Type 2 Diabetes - an International Observation
OBSERVATIONAL
Inicio: 10 de dic de 2018
ID: NCT03811288
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00549757
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros